It is known that VLDL-1 cholesterol levels are correlated with ApoE4, that in turn is a factor that affect the Aβ levels: when a patient shows altered ApoE4 function, AD-related risks increase multiple-fold (Kloske and Wilcock, 2020). Here, APOE is linked to Alzheimer disease.